COSMO Pharmaceuticals N.V.
Specialty pharma for gastroenterology/dermatology, offering colon treatments & manufacturing services.
COPN | SW
Overview
Corporate Details
- ISIN(s):
- NL0011832936
- LEI:
- 724500OX0EBQRYTVV639
- Country:
- Netherlands
- Address:
- Sir Rogerson's Quay Riverside II, Dublin 2 Dublin
- Website:
- https://www.cosmopharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
COSMO Pharmaceuticals N.V. is a specialty pharmaceutical company focused on developing and commercializing products for gastroenterology, dermatology, and healthtech. The company's therapeutic focus is on the oral and endoscopic treatment of colon diseases, including bowel diseases and colorectal cancer prevention, utilizing its proprietary MMX® technology. In addition to its own pipeline, Cosmo provides manufacturing services to other pharmaceutical companies. These services cover the production of solid, semi-solid, and liquid oral medicines and include process assessment, technology transfer, stability testing, market release, and regulatory documentation support.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-09-02 02:00 |
Cosmo Pharmaceuticals Highlights Study Published in “The Lancet” Demonstrating …
|
English | 7.3 KB | ||
| 2024-09-02 02:00 |
Cosmo Pharmaceuticals weist auf Studie hin, die in «The Lancet» veröffentlicht…
|
German | 7.8 KB | ||
| 2024-07-31 02:00 |
Cosmo Intelligent Medical Devices Unveils Next Generation GI Genius™ Hardware w…
|
English | 7.6 KB | ||
| 2024-07-31 02:00 |
Cosmo Intelligent Medical Devices stellt die nächste Generation der GI Genius™…
|
German | 9.3 KB | ||
| 2024-07-24 02:00 |
Cosmo achieves robust financial performance in H1 2024 and confirms its full ye…
|
English | 28.6 KB | ||
| 2024-07-24 02:00 |
Cosmo berichtet robuste Finanzergebnisse im 1. Halbjahr 2024 und bestätigt den…
|
German | 31.0 KB | ||
| 2024-07-09 02:00 |
Invitation to Cosmo’s Half-Year 2024 Webcast on 24 July 2024
|
English | 6.7 KB | ||
| 2024-07-09 02:00 |
Einladung zum H1 2024-Webcast von Cosmo am 24. Juli 2024
|
German | 7.0 KB | ||
| 2024-07-05 02:00 |
Cosmo shareholders approved all resolutions proposed by the Board of Directors …
|
English | 6.8 KB | ||
| 2024-07-05 02:00 |
Aktionärinnen und Aktionäre von Cosmo genehmigten an der ausserordentlichen Gen…
|
German | 7.5 KB | ||
| 2024-06-18 02:00 |
Cosmo’s oral diagnostic drug Lumeblue® receives approval of New Drug Applicatio…
|
English | 11.3 KB | ||
| 2024-06-18 02:00 |
Das orale Diagnostikum Lumeblue® von Cosmo erhält Zulassung als neues Medikamen…
|
German | 11.5 KB | ||
| 2024-06-03 02:00 |
Cosmo to bring real-time AI into intelligent medical devices with NVIDIA IGX
|
English | 8.9 KB | ||
| 2024-06-03 02:00 |
Cosmo bringt mit NVIDIA IGX die Künstliche Intelligenz (KI) in Echtzeit in inte…
|
German | 9.8 KB | ||
| 2024-05-31 02:00 |
Cosmo reports excellent final Full Year 2023 financial results - Increases oper…
|
English | 38.0 KB |
Automate Your Workflow. Get a real-time feed of all COSMO Pharmaceuticals N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for COSMO Pharmaceuticals N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for COSMO Pharmaceuticals N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
